1
|
San Juan JL, Fernández CM, Almaguer M, Perurena MR, Martínez GF, Velar RE, Illnait MT. [In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin]. BIOMEDICA : REVISTA DEL INSTITUTO NACIONAL DE SALUD 2017; 37:451-459. [PMID: 29373765 DOI: 10.7705/biomedica.v37i4.3447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Revised: 11/28/2016] [Indexed: 06/07/2023]
Abstract
INTRODUCTION The behavior of antifungal susceptibility of Aspergillus spp. in Cuba remains unknown. The antifungals recommended to treat aspergillosis are amphotericin B, itraconazole, voriconazole and echinocandins. The influence of the environment may set off the emergence of drug-resistance in these microorganisms. OBJECTIVE To evaluate in vitro susceptibility of Aspergillus spp. strains to amphotericin B, itraconazole and voriconazol, and the relationship between susceptibility patterns and their origin. MATERIALS AND METHODS Minimum inhibitory concentrations of amphotericin B, itraconazole and voriconazole were determined for 60 Aspergillus spp. strains of clinical and environmental origin using the M38-A2 method of the Clinical and Laboratory Standards Institute. RESULTS We found 21 amphotericin B resistant strains (mainly from clinical samples and hospital environments), as well as three itraconazole resistant strains (from non-hospital outdoor and indoor environments). No voriconazole resistance was found. No relationship was found between strain origin and susceptibility. CONCLUSIONS Results suggest the possible existence of environmental factors or interactions with resistant genotypes which may give rise to resistant phenotypes in our country. This is the first report of in vitro Aspergillus spp. resistant strains in Cuba. These studies should be broadened and include molecular and phylogenetic analyses.
Collapse
Affiliation(s)
- Javier L San Juan
- Laboratorio Nacional de Referencia de Micología, Instituto de Medicina Tropical "Pedro Kourí", La Habana, Cuba.
| | | | | | | | | | | | | |
Collapse
|
2
|
Sanchis M, Capilla J, Mayayo E, Pastor FJ, Guarro J. Experimental efficacy of anidulafungin againstAspergillus terreusspecies complex. Med Mycol 2015; 53:630-5. [DOI: 10.1093/mmy/myv027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Accepted: 03/25/2015] [Indexed: 11/13/2022] Open
|
3
|
Lago M, Aguiar A, Natário A, Fernandes C, Faria M, Pinto E. Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species? ENVIRONMENTAL MONITORING AND ASSESSMENT 2014; 186:5581-5593. [PMID: 24833021 DOI: 10.1007/s10661-014-3804-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Accepted: 04/30/2014] [Indexed: 06/03/2023]
Abstract
This study assessed if the use of sterol demethylase inhibitor fungicides in vineyard production can induce resistance to azoles in Aspergillus strains and if it can induce selection of resistant species. We also tried to identify the Aspergillus species most prevalent in the vineyards. Two vineyards from northern Portugal were selected from "Vinhos Verdes" and "Douro" regions. The vineyards were divided into plots that were treated or not with penconazole (PEN). In each vineyard, air, soil, and plant samples were collected at three different times. The strains of Aspergillus spp. were isolated and identified by morphological and molecular techniques. We identified 46 Aspergillus section Nigri, eight Aspergillus fumigatus, seven Aspergillus lentulus, four Aspergillus wentii, two Aspergillus flavus, two Aspergillus terreus, one Aspergillus calidoustus, one Aspergillus westerdijkiae, one Aspergillus tamarii, and one Eurotium amstelodami. Aspergillus strains were evaluated for their susceptibility to medical azoles used in human therapy (itraconazole, posaconazole, and voriconazole) and to agricultural azoles (PEN) used in the prevention and treatment of plant diseases. The isolates showed moderate susceptibility to voriconazole. We did not observe any decrease of susceptibility to the medical azoles tested throughout the testing period in any of the treated plots, although some of the resistant species were isolated from there.
Collapse
Affiliation(s)
- Magali Lago
- CEQUIMED-UP/Serviço de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal
| | | | | | | | | | | |
Collapse
|
4
|
Lass-Flörl C. Susceptibility testing in Aspergillus species complex. Clin Microbiol Infect 2014; 20 Suppl 6:49-53. [PMID: 24372722 DOI: 10.1111/1469-0691.12514] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2013] [Revised: 11/18/2013] [Accepted: 11/18/2013] [Indexed: 11/27/2022]
Abstract
Methods for susceptibility testing of Aspergillus are developed and validated by the European Committee on Antibiotic Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing. Breakpoints for phenotypic antimicrobial susceptibility testing have been determined by breakpoint committees and as part of regulatory processes for the approval of new drugs. Dosages, pharmacokinetics, resistance mechanisms, MIC distributions, pharmacodynamics and epidemiological cut-off values are used in the breakpoint-setting process. Clinical breakpoints are for everyday use in the clinical laboratory to advise on patient therapy. Resistance in Aspergillus fumigatus has been increasingly reported since standards became available.
Collapse
Affiliation(s)
- C Lass-Flörl
- Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria
| |
Collapse
|
5
|
DiMondi VP, Drew RH. Aerosolized Antifungals for the Prevention and Treatment of Invasive Fungal Infections. CURRENT FUNGAL INFECTION REPORTS 2013. [DOI: 10.1007/s12281-013-0137-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model. Antimicrob Agents Chemother 2013; 57:1404-8. [PMID: 23295918 DOI: 10.1128/aac.01331-12] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We have evaluated the in vitro activity of voriconazole against 61 strains of Aspergillus fumigatus by using broth microdilution, disk diffusion, and minimal fungicidal concentration procedures. We observed an excellent correlation between the results obtained with the three methods. Five percent of the strains showed MICs greater than or equal to the epidemiological cutoff value (ECV; 1 μg/ml). To assess whether MICs were predictive of in vivo outcome, we tested the efficacy of voriconazole at 25 mg/kg of body weight daily in an immunosuppressed murine model of disseminated infection using 10 strains representing various patterns of susceptibility to the drug as determined by the in vitro study. Voriconazole prolonged survival and reduced fungal load in the kidneys and brain in those mice infected with strains with MICs of ≤0.25 μg/ml, while in mice infected with strains with MICs of 0.5 to 2 μg/ml, the efficacy was varied and strain dependent and in mice infected with the strain with a MIC of 4 μg/ml, the antifungal did not show efficacy. Voriconazole reduced galactomannan antigenemia against practically all strains with a MIC of <4 μg/ml. Our results demonstrate that some relationship exists between voriconazole MICs and in vivo efficacy; however, further studies testing additional strains are needed to better ascertain which MIC values can predict clinical outcome.
Collapse
|
7
|
Gutierrez LJ, Mascotti ML, Kurina-Sanz M, Pungitore CR, Enriz RD, Giannini FA. Cinnamic Acid Derivatives Acting against Aspergillus Fungi.Taq Polymerase I a Potential Molecular Target. Nat Prod Commun 2012. [DOI: 10.1177/1934578x1200701225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Some members of a series of cinnamic acid derivatives possess promising inhibitory activities in cellular assays against fungi of the Aspergillus genus. In order to search for a possible molecular target of such compounds, their role as Taq polymerase I inhibitors was studied. Four of the compounds studied displayed IC50 values within the range of those considered active as DNA polymerase inhibitors when searching for new cytotoxic molecules. The results obtained in our molecular modeling study appear to show that the inhibitory activity depends on the presence of a stabilizing interaction between the phenylpropanoid derivatives and the residues Asp610, Thr664, Phe667, Tyr671, and Asp785 located in the active site of Taq polymerase I. Also, it is possible to assert that the polymerization of DNA would be the molecular target of cinnamic acid derivatives with antifungal activity, which correlates with the inhibition of Taq polymerase I and the quantitative descriptor for the lipophilia (ClogP).
Collapse
Affiliation(s)
- Lucas J. Gutierrez
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
- Instituto Multidisciplinario de Investigaciones Biológicas de San Luis (UNSL, CONICET), Ejército de Los Andes 950, 5700 San Luis, Argentina
| | - Maria L. Mascotti
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
- Instituto de Tecnología Química de San Luis (UNSL, CONICET), Chacabuco 917-5700-San Luis, Argentina
| | - Marcela Kurina-Sanz
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
- Instituto de Tecnología Química de San Luis (UNSL, CONICET), Chacabuco 917-5700-San Luis, Argentina
| | - Carlos R. Pungitore
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
- Instituto de Tecnología Química de San Luis (UNSL, CONICET), Chacabuco 917-5700-San Luis, Argentina
| | - Ricardo D. Enriz
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
- Instituto Multidisciplinario de Investigaciones Biológicas de San Luis (UNSL, CONICET), Ejército de Los Andes 950, 5700 San Luis, Argentina
| | - Fernando A. Giannini
- Departamento de Química, Facultad de Química, Bioquímica y Farmacia. Universidad Nacional de San Luis (UNSL), Chacabuco 917-5700-San Luis, Argentina
| |
Collapse
|
8
|
Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, Ayadi A, Ranque S. Amphotericin Bin vitroresistance is associated with fatalAspergillus flavusinfection. Med Mycol 2012; 50:829-34. [DOI: 10.3109/13693786.2012.684154] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Interaction of platelets and anidulafungin against Aspergillus fumigatus. Antimicrob Agents Chemother 2012; 57:626-8. [PMID: 23114752 DOI: 10.1128/aac.01534-12] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The combination of platelets and anidulafungin at 0.03 μg/ml significantly (P < 0.05) reduced the germination rate and hyphal elongation in Aspergillus fumigatus compared to those with either anidulafungin only or an untreated control. Platelets decreased the expression of the fks gene, which plays an important role in cell wall synthesis. Our results suggest that human platelets plus anidulafungin might contribute to defense against A. fumigatus.
Collapse
|
10
|
Schmalreck A, Willinger B, Czaika V, Fegeler W, Becker K, Blum G, Lass-Flörl C. Susceptibility screening of hyphae-forming fungi with a new, easy, and fast inoculum preparation method. Mycopathologia 2012; 174:467-74. [PMID: 22864604 DOI: 10.1007/s11046-012-9570-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2012] [Accepted: 07/19/2012] [Indexed: 11/30/2022]
Abstract
In vitro susceptibility testing of clinically important fungi becomes more and more essential due to the rising number of fungal infections in patients with impaired immune system. Existing standardized microbroth dilution methods for in vitro testing of molds (CLSI, EUCAST) are not intended for routine testing. These methods are very time-consuming and dependent on sporulating of hyphomycetes. In this multicentre study, a new (independent of sporulation) inoculum preparation method (containing a mixture of vegetative cells, hyphae, and conidia) was evaluated. Minimal inhibitory concentrations (MIC) of amphotericin B, posaconazole, and voriconazole of 180 molds were determined with two different culture media (YST and RPMI 1640) according to the DIN (Deutsches Institut für Normung) microdilution assay. 24 and 48 h MIC of quality control strains, tested per each test run, prepared with the new inoculum method were in the range of DIN. YST and RPMI 1640 media showed similar MIC distributions for all molds tested. MIC readings at 48 versus 24 h yield 1 log(2) higher MIC values and more than 90 % of the MICs read at 24 and 48 h were within ± 2 log(2) dilution. MIC end point reading (log(2 MIC-RPMI 1640)-log(2 MIC-YST)) of both media demonstrated a tendency to slightly lower MICs with RPMI 1640 medium. This study reports the results of a new, time-saving, and easy-to-perform method for inoculum preparation for routine susceptibility testing that can be applied for all types of spore-/non-spore and hyphae-forming fungi.
Collapse
|
11
|
Colozza C, Posteraro B, Santilli S, De Carolis E, Sanguinetti M, Girmenia C. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies. Int J Antimicrob Agents 2012; 39:440-3. [DOI: 10.1016/j.ijantimicag.2012.01.013] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2011] [Revised: 01/19/2012] [Accepted: 01/20/2012] [Indexed: 11/29/2022]
|
12
|
Hadrich I, Makni F, Neji S, Abbes S, Cheikhrouhou F, Trabelsi H, Sellami H, Ayadi A. Invasive Aspergillosis: Resistance to Antifungal Drugs. Mycopathologia 2012; 174:131-41. [DOI: 10.1007/s11046-012-9526-y] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2011] [Accepted: 01/23/2012] [Indexed: 11/29/2022]
|
13
|
Lass-Flörl C. In vitro susceptibility testing in Aspergillus species: an update. Future Microbiol 2010; 5:789-99. [PMID: 20441550 DOI: 10.2217/fmb.10.34] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aspergillus species are the most common causes of invasive mold infections in immunocompromised patients. The introduction of new antifungal agents and recent reports of resistance emerging during treatment of Aspergillus infections have highlighted the need for in vitro susceptibility testing. Various testing procedures have been proposed, including macro- and micro-dilution, disk diffusion, Etest (AB Biodisk, Sweden) and other commercial tests. Although Aspergillus species are generally susceptible to various compounds, intrinsic and acquired resistance has been documented. Amphotericin B has limited activity against Aspergillus terreus and Aspergillus nidulans. Not surprisingly, continued use of azole-based drugs has the undesirable consequence of elevating the resistance of subsequent isolates from these patients. Several species in the Aspergillus fumigatus complex appear to be resistant to azoles; there is evidence of in vitro and in vivo correlation. Each in vitro susceptibility testing method has its own advantages and disadvantages. Etest is easy to perform and use on a daily basis, yet it is expensive. Disk diffusion is the most attractive alternative method to date, yet we lack sufficient data for aspergilli. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Clinical Laboratory Standard Institute (CLSI) have produced reproducible reference testing methods. This article reviews the available methods for antifungal susceptibility testing in Aspergillus spp. as well as the scant data regarding the clinical implications of in vitro testing.
Collapse
Affiliation(s)
- Cornelia Lass-Flörl
- Department of Hygiene, Microbiology & Social Medicine, Division of Hygiene & Clinical Microbiology, Innsbruck Medical University, Fritz Pregl Str 3, 6020 Innsbruck, Austria.
| |
Collapse
|
14
|
Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12:141-7. [DOI: 10.1016/j.drup.2009.09.002] [Citation(s) in RCA: 209] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2009] [Accepted: 06/08/2009] [Indexed: 11/24/2022]
|
15
|
Auberger J, Lass-Flörl C, Clausen J, Bellmann R, Buzina W, Gastl G, Nachbaur D. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis 2008; 62:336-9. [DOI: 10.1016/j.diagmicrobio.2008.06.012] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2008] [Revised: 06/12/2008] [Accepted: 06/17/2008] [Indexed: 10/21/2022]
|
16
|
Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008; 74:7023-35. [PMID: 18820063 DOI: 10.1128/aem.01288-08] [Citation(s) in RCA: 79] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Aspergillus fumigatus is the main cause of invasive aspergillosis in immunocompromised patients, and only a limited number of drugs for treatment are available. A screening method for new antifungal compounds is urgently required, preferably an approach suitable for in vitro and in vivo studies. Bioluminescence imaging is a powerful tool to study the temporal and spatial resolutions of the infection and the effectiveness of antifungal drugs. Here, we describe the construction of a bioluminescent A. fumigatus strain by fusing the promoter of the glyceraldehyde-3-phosphate dehydrogenase gene from A. fumigatus with the luciferase gene from Photinus pyralis to control the expression of the bioluminescent reporter. A. fumigatus transformed with this construct revealed high bioluminescence under all tested growth conditions. Furthermore, light emission correlated with the number of conidia used for inoculation and with the biomass formed after different incubation times. The bioluminescent strains were suitable to study the effectiveness of antifungals in vitro by several independent methods, including the determination of light emission with a microplate reader and the direct visualization of light emission with an IVIS 100 system. Moreover, when glucocorticoid-treated immunosuppressed mice were infected with a bioluminescent strain, light emission was detected from infected lungs, allowing the visualization of the progression of invasive aspergillosis. Therefore, this new bioluminescence tool is suitable to study the in vitro effectiveness of drugs and the disease development, localization, and burden of fungi within tissues and may also provide a powerful tool to study the effectiveness of antifungals in vivo.
Collapse
|